Lefax (Simeticone)

Simeticone reduces the surface tension of gas bubbles in the GI tract, causing them to coalesce into larger bubbles that can be more easily expelled through belching or flatulence, thereby decreasing the sensation of gas‑related discomfort.

The dose of Lefax is determined by the prescribing healthcare professional based on the patient’s age, weight, and severity of symptoms. Patients should follow the instructions on the product label or those given by their clinician and not exceed the recommended amount.

Safety data for simeticone in pregnancy and lactation are limited. It is generally considered low risk because it is not absorbed systemically, but pregnant or nursing women should consult their healthcare provider before using Lefax.

To place an order, submit an enquiry on the Lefax product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Lefax’s active ingredient, simeticone, is the most widely used antiflatulent and works by physically altering gas bubbles, unlike antacids or probiotics that modify gastric acidity or gut flora. Its mechanism provides rapid symptom relief with minimal systemic absorption, making it comparable or superior to many over‑the‑counter gas‑relief options.

Lefax should be stored at room temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and effectiveness.

Lefax is taken orally, usually as chewable tablets, capsules or liquid drops, depending on the product form. The tablet or capsule should be swallowed with water, and the liquid form can be measured with the supplied dropper and taken directly or mixed with a small amount of food or drink.

Although rare, serious adverse reactions can include severe allergic responses such as anaphylaxis, angioedema, or extensive skin rash. If any signs of a serious allergic reaction occur, the product should be discontinued immediately and medical attention sought.

Individuals with a known hypersensitivity to simeticone or any excipients in the formulation should avoid Lefax. Additionally, patients with swallowing difficulties or those who have not received appropriate dosing guidance for children should not use the product without professional advice.